Next Article in Journal
Metabolic Heterogeneity in Diffuse Large B-Cell Lymphoma Cells Reveals an Innovative Antimetabolic Combination Strategy
Next Article in Special Issue
Efficacy and Toxicity of Bevacizumab in Children with NF2-Related Schwannomatosis: A Systematic Review
Previous Article in Journal
Timing Anti-PD-L1 Checkpoint Blockade Immunotherapy to Enhance Tumor Irradiation
Previous Article in Special Issue
A Mixed Methods Study of Medication Adherence in Adults with Neurofibromatosis Type 1 (NF1) on a Clinical Trial of Selumetinib
 
 
Article

Article Versions Notes

Cancers 2025, 17(3), 393; https://doi.org/10.3390/cancers17030393
Action Date Notes Link
article pdf uploaded. 24 January 2025 16:24 CET Version of Record https://www.mdpi.com/2072-6694/17/3/393/pdf-vor
article supplementary file uploaded. 24 January 2025 16:24 CET - https://www.mdpi.com/2072-6694/17/3/393#supplementary
article xml file uploaded 7 February 2025 10:37 CET Original file -
article xml uploaded. 7 February 2025 10:37 CET Update https://www.mdpi.com/2072-6694/17/3/393/xml
article pdf uploaded. 7 February 2025 10:37 CET Updated version of record https://www.mdpi.com/2072-6694/17/3/393/pdf
article html file updated 7 February 2025 10:40 CET Original file https://www.mdpi.com/2072-6694/17/3/393/html
Back to TopTop